Search research articles
Contact Us
Filters
Showing results (251-260 of 265) with videos related to
Page
of 27
Sort By:
Nature Communications
|
February 8, 2017
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
Cheng Xue Qin, Lauren T May, Renming Li, et al.
Journal of Molecular and Cellular Cardiology
|
March 14, 2024
Myocardial glycophagy flux dysregulation and glycogen accumulation characterize diabetic cardiomyopathy
Kimberley M Mellor, Upasna Varma, Parisa Koutsifeli, et al.
Scientific Reports
|
May 4, 2018
Author Correction: Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo
Cheng Xue Qin, Siobhan B Finlayson, Annas Al-Sharea, et al.
Cardiovascular Research
|
February 12, 2021
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart
Darnel Prakoso, Shiang Y Lim, Jeffrey R Erickson, et al.
Frontiers in Physiology
|
September 7, 2021
Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
Mitchel Tate, Darnel Prakoso, Andrew M Willis, et al.
Frontiers in Physiology
|
December 5, 2019
Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
Mitchel Tate, Darnel Prakoso, Andrew M Willis, et al.
Scientific Reports
|
December 2, 2017
Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo
Cheng Xue Qin, Siobhan B Finlayson, Annas Al-Sharea, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 8, 2021
Guidelines for in vivo mouse models of myocardial infarction
Merry L Lindsey, Keith R Brunt, Jonathan A Kirk, et al.
Stem Cell Research & Therapy
|
December 5, 2025
Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injury
Andrew R Kompa, David W Greening, Jarmon G Lees, et al.
European Heart Journal
|
April 13, 2021
A call to action for new global approaches to cardiovascular disease drug solutions
Gemma A Figtree, Keith Broadfoot, Barbara Casadei, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 265) with videos related to
Sort By:
Page
of 27
Nature Communications
|
February 8, 2017
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
Cheng Xue Qin, Lauren T May, Renming Li, et al.
Journal of Molecular and Cellular Cardiology
|
March 14, 2024
Myocardial glycophagy flux dysregulation and glycogen accumulation characterize diabetic cardiomyopathy
Kimberley M Mellor, Upasna Varma, Parisa Koutsifeli, et al.
Scientific Reports
|
May 4, 2018
Author Correction: Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo
Cheng Xue Qin, Siobhan B Finlayson, Annas Al-Sharea, et al.
Cardiovascular Research
|
February 12, 2021
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart
Darnel Prakoso, Shiang Y Lim, Jeffrey R Erickson, et al.
Frontiers in Physiology
|
September 7, 2021
Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
Mitchel Tate, Darnel Prakoso, Andrew M Willis, et al.
Frontiers in Physiology
|
December 5, 2019
Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
Mitchel Tate, Darnel Prakoso, Andrew M Willis, et al.
Scientific Reports
|
December 2, 2017
Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo
Cheng Xue Qin, Siobhan B Finlayson, Annas Al-Sharea, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 8, 2021
Guidelines for in vivo mouse models of myocardial infarction
Merry L Lindsey, Keith R Brunt, Jonathan A Kirk, et al.
Stem Cell Research & Therapy
|
December 5, 2025
Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injury
Andrew R Kompa, David W Greening, Jarmon G Lees, et al.
European Heart Journal
|
April 13, 2021
A call to action for new global approaches to cardiovascular disease drug solutions
Gemma A Figtree, Keith Broadfoot, Barbara Casadei, et al.
Page
of 27